| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.34 | 0.04 |